Drug resistance associated with altered DNA topoisomerase II

Advances in Enzyme Regulation

Volumn 33, Issue C, 1993, Pages 113-116

  Beck, William T ^a,b   Danks, Mary K ^a   Wolverton, Judith S ^a   Kim, Ryungsa ^a   Chen, Mei ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING);

CELL CULTURE; DRUG EFFECT; DRUG RESISTANCE; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; HUMAN; METABOLISM; PHENOTYPE; PHYSIOLOGY; REVIEW;

ANTINEOPLASTIC AGENTS; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE; HUMAN; PHENOTYPE; POLYMORPHISM (GENETICS); SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0027484836     PISSN: 00652571     EISSN: None     Source Type: Journal    
DOI: 10.1016/0065-2571(93)90012-3     Document Type: Article

References (21)

1. Amplification of a novel v-erbB related gene in a human mammary carcinoma
2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
3. A v-erbB-related protoncogene, c-erbB-2 is distinct from the c-erbB-1/epidermal growth factor receptor gene and is amplified in a human salivary gland adenocarcinoma
4. Molecular themes in oncogenesis
5. Overexpression of the EGF receptor-related protooncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms
6. Studies of therapy HER-2/neu protoncogene in human breast and ovarian cancer
7. Correlation of c-erbB-2 gene amplification and protein expression in human breast cancer with nodal status and nuclear grading
8. The neu oncogene encodes an epidermal growth factor receptor-related protein
9. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor
10. The product of the c-erbB-2 gene: A 185 kd phosphoprotein with tyrosine kinase activity
11. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells
12. Increased expression of the putative growth factor receptor p185 (HER2) causes transformation and tumorigenesis of NIH/3T3 cells
13. Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer
14. Single chain antigen binding proteins
15. Recombinant toxins for cancer treatment
16. Recombinant anti-erbB-2 immunotoxins containing pseudomonas exotoxin
17. Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies
18. In vivo tumor targeting of a recombinant single-chain antigen binding protein
19. Amplification, overexpression and rearrangement of the erbB-2 proto-oncogene in primary human stomach carcinomas
20. Amplification and expression of the c-erbB-2/neu protooncogene in human bladder cancer
21. Overexpression for the c-erbB-2/neu-encoded p185 protein in primary lung cancer